SEARCH

SEARCH BY CITATION

References

  • Albrecht M. A., Colegrove S. L. and Friel D. D. (2002) Differential regulation of ER Ca2+ uptake and release rates accounts for multiple modes of Ca2+-induced Ca2+ release. J. Gen. Physiol. 119, 211233.
  • Altar C. A., Boylan C. B., Fritsche M., Jones B. E., Jackson C., Wiegand S. J., Lindsay R. M. and Hyman C. (1994) Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J. Neurochem. 63, 10211032.
  • Balkowiec A. and Katz D. M. (2000) Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J. Neurosci. 20, 74177423.
  • Balkowiec A. and Katz D. M. (2002) Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J. Neurosci. 22, 10 39910 407.
  • Bartlett S. E., Enquist J., Hopf F. W. et al. (2005) Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc. Natl Acad. Sci. USA 102, 11 52111 526.
  • Berke J. D., Paletzki R. F., Aronson G. J., Hyman S. E. and Gerfen C. R. (1998) A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18, 53015310.
  • Blochl A. and Sirrenberg C. (1996) Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J. Biol. Chem. 271, 21 10021 107.
  • Bonci A. and Hopf F. W. (2005) The dopamine D2 receptor: new surprises from an old friend. Neuron 47, 335338.
  • Brady R., Zaidi S. I., Mayer C. and Katz D. M. (1999) BDNF is a target-derived survival factor for arterial baroreceptor and chemoafferent primary sensory neurons. J. Neurosci. 19, 21312142.
  • Brito V., Beyer C. and Kuppers E. (2004) BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling. Glia 46, 284295.
  • Canossa M., Giordano E., Cappello S., Guarnieri C. and Ferri S. (2002) Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proc. Natl Acad. Sci. USA 99, 32823287.
  • Conforti L., Bodi I., Nisbet J. W. and Millhorn D. E. (2000) O2-sensitive K+ channels: role of the Kv1.2-subunit in mediating the hypoxic response. J. Physiol. 524 Part 3, 783793.
  • Courtney N. D., Howlett A. C. and Westfall T. C. (1991) Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein. Neurosci. Lett. 122, 261264.
  • De Lean A., Kilpatrick B. F. and Caron M. G. (1982) Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists. Mol Pharmacol. 22, 290297.
  • Di Virgilio F., Milani D., Leon A., Meldolesi J. and Pozzan T. (1987) Voltage-dependent activation and inactivation of calcium channels in PC12 cells. Correlation with neurotransmitter release. J. Biol. Chem. 262, 91899195.
  • Ermak G. and Davies K. J. (2002) Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol. 38, 713721.
  • Fang H., Chartier J., Sodja C., Desbois A., Ribecco-Lutkiewicz M., Walker P. R. and Sikorska M. (2003) Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons. J. Biol. Chem. 278, 26 40126 409.
  • Frim D. M., Uhler T. A., Galpern W. R., Beal M. F., Breakefield X. O. and Isacson O. (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl Acad. Sci. USA 91, 51045108.
  • Gerlach M., Double K., Arzberger T., Leblhuber F., Tatschner T. and Riederer P. (2003) Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J. Neural Transm 110, 11191127.
  • Goggi J., Pullar I. A., Carney S. L. and Bradford H. F. (2003) Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res. 968, 156161.
  • Goldstein M., Harada K., Meller E., Schalling M. and Hokfelt T. (1990) Dopamine autoreceptors. Biochemical, pharmacological, and morphological studies. Ann. N Y Acad. Sci. 604, 169175.
  • Goodman L. J., Valverde J., Lim F., Geschwind M. D., Federoff H. J., Geller A. I. and Hefti F. (1996) Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci. 7, 222238.
  • Greene L. A. and Rein G. (1977) Release of (3H) norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation. Brain Res. 138, 521528.
  • Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J. C. and Sokoloff P. (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 8689.
  • Guillin O., Griffon N., Bezard E., Leriche L., Diaz J., Gross C. and Sokoloff P. (2003) Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. Eur. J. Pharmacol. 480, 8995.
  • Guo H., Tang Z., Yu Y., Xu L., Jin G. and Zhou J. (2002) Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur. J. Neurosci. 16, 18611870.
  • Hernandez-Lopez S., Tkatch T., Perez-Garci E., Galarraga E., Bargas J., Hamm H. and Surmeier D. J. (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 89878995.
  • Heymach J. V. Jr and Shooter E. M. (1995) The biosynthesis of neurotrophin heterodimers by transfected mammalian cells. J. Biol. Chem. 270, 12 29712 304.
  • Heymach J. V. Jr, Kruttgen A., Suter U. and Shooter E. M. (1996) The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cells. J. Biol. Chem. 271, 25 43025 437.
  • Hughes P. E., Alexi T., Walton M., Williams C. E., Dragunow M., Clark R. G. and Gluckman P. D. (1999) Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog. Neurobiol. 57, 421450.
  • Kim D. K., Natarajan N., Prabhakar N. R. and Kumar G. K. (2004) Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species. J. Appl. Physiol. 96, 12061215; discussion 1196.
  • Kourie J. I. (1998) Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 275, C1C24.
  • Kruttgen A., Moller J. C., Heymach J. V. Jr and Shooter E. M. (1998) Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc. Natl Acad. Sci. USA 95, 96149619.
  • Kumar G. K., Overholt J. L., Bright G. R., Hui K. Y., Lu H., Gratzl M. and Prabhakar N. R. (1998) Release of dopamine and norepinephrine by hypoxia from PC-12 cells. Am. J. Physiol. 274, C1592C1600.
  • Kuppers E. and Beyer C. (2001) Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport 12, 11751179.
  • Lindvall O., Ernfors P., Bengzon J., Kokaia Z., Smith M. L., Siesjo B. K. and Persson H. (1992) Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl Acad. Sci. USA 89, 648652.
  • Liu H., Felix R., Gurnett C. A., De Waard M., Witcher D. R. and Campbell K. P. (1996) Expression and subunit interaction of voltage-dependent Ca2+ channels in PC12 cells. J. Neurosci. 16, 75577565.
  • Mattson M. P. and Scheff S. W. (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma 11, 333.
  • Mattson M. P., Lovell M. A., Furukawa K. and Markesbery W. R. (1995) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 17401751.
  • Mattson M. P., Duan W. and Maswood N. (2002) How does the brain control lifespan? Ageing Res. Rev. 1, 155165.
  • Millan M. J., Maiofiss L., Cussac D., Audinot V., Boutin J. A. and Newman-Tancredi A. (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J. Pharmacol. Exp. Ther. 303, 791804.
  • Moller J. C., Kruttgen A., Heymach J. V. Jr, Ghori N. and Shooter E. M. (1998) Subcellular localization of epitope-tagged neurotrophins in neuroendocrine cells. J. Neurosci. Res. 51, 463472.
  • Neal M., Cunningham J., Lever I., Pezet S. and Malcangio M. (2003) Mechanism by which brain-derived neurotrophic factor increases dopamine release from the rabbit retina. Invest. Ophthalmol. Vis. Sci. 44, 791798.
  • Okazawa H., Murata M., Watanabe M., Kamei M. and Kanazawa I. (1992) Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Lett. 313, 138142.
  • Peng Y. J., Overholt J. L., Kline D., Kumar G. K. and Prabhakar N. R. (2003) Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc. Natl Acad. Sci. USA 100, 10 07310 078.
  • Petersen A. A., Larsen K. E., Behr G. G., Romero N., Przedborski S., Brundin P. and Sulzer D. (2001) Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res. Bull. 56, 331335.
  • Pothos E. N., Przedborski S., Davila V., Schmitz Y. and Sulzer D. (1998) D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J. Neurosci. 18, 55755585.
  • Pozzan T., Gatti G., Dozio N., Vicentini L. M. and Meldolesi J. (1984) Ca2+-dependent and -independent release of neurotransmitters from PC12 cells: a role for protein kinase C activation? J. Cell Biol. 99, 628638.
  • Ritchie A. K. (1979) Catecholamine secretion in a rat pheochromocytoma cell line: two pathways for calcium entry. J. Physiol. 286, 541561.
  • Row B. W., Liu R., Xu W., Kheirandish L. and Gozal D. (2003) Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am. J. Respir. Crit. Care Med. 167, 15481553.
  • Saarelainen T., Lukkarinen J. A., Koponen S. et al. (2000) Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia. Mol. Cell. Neurosci. 16, 8796.
  • Sadakata T., Mizoguchi A., Sato Y., Katoh-Semba R., Fukuda M., Mikoshiba K. and Furuichi T. (2004) The secretory granule-associated protein CAPS2 regulates neurotrophin release and cell survival. J. Neurosci. 24, 4352.
  • Schubert D. and Klier F. G. (1977) Storage and release of acetylcholine by a clonal cell line. Proc. Natl Acad. Sci. USA 74, 51845188.
  • Seroogy K. B., Lundgren K. H., Tran T. M., Guthrie K. M., Isackson P. J. and Gall C. M. (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321334.
  • Seta K., Kim H. W., Ferguson T., Kim R., Pathrose P., Yuan Y., Lu G., Spicer Z. and Millhorn D. E. (2002) Genomic and physiological analysis of oxygen sensitivity and hypoxia tolerance in PC12 cells. Ann. N Y Acad. Sci. 971, 379388.
  • Sokoloff P., Guillin O., Diaz J., Carroll P. and Griffon N. (2002) Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders. Neurotox. Res. 4, 671678.
  • Takeuchi Y., Miyamoto E. and Fukunaga K. (2002) Analysis on the promoter region of exon IV brain-derived neurotrophic factor in NG108-15 cells. J. Neurochem. 83, 6779.
  • Taylor S. C. and Peers C. (1998) Hypoxia evokes catecholamine secretion from rat pheochromocytoma PC-12 cells. Biochem. Biophys. Res. Commun. 248, 1317.
  • Tsukahara T., Takeda M., Shimohama S., Ohara O. and Hashimoto N. (1995) Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery 37, 733739; discussion 739–741.
  • Usowicz M. M., Porzig H., Becker C. and Reuter H. (1990) Differential expression by nerve growth factor of two types of Ca2+ channels in rat phaeochromocytoma cell lines. J. Physiol. 426, 95116.
  • Walton M., Connor B., Lawlor P., Young D., Sirimanne E., Gluckman P., Cole G. and Dragunow M. (1999) Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res. Brain Res. Rev. 29, 137168.
  • Wu Y. J., Kruttgen A., Moller J. C., Shine D., Chan J. R., Shooter E. M. and Cosgaya J. M. (2004) Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 are sorted to dense-core vesicles and released via the regulated pathway in primary rat cortical neurons. J. Neurosci. Res. 75, 825834.
  • Xu W., Chi L., Row B. W., Xu R., Ke Y., Xu B., Luo C., Kheirandish L., Gozal D. and Liu R. (2004) Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126, 313323.
  • Yan Z., Feng J., Fienberg A. A. and Greengard P. (1999) D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl Acad. Sci. USA 96, 11 60711 612.
  • Yuan G., Adhikary G., McCormick A. A., Holcroft J. J., Kumar G. K. and Prabhakar N. R. (2004) Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J. Physiol. 557, 773783.
  • Zhu W. H., Conforti L., Czyzyk-Krzeska M. F. and Millhorn D. E. (1996) Membrane depolarization in PC-12 cells during hypoxia is regulated by an O2-sensitive K+ current. Am. J. Physiol. 271, C658C665.